Biobank: ATBC Study (Finland): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 1: Line 1:
{{forresearchers}}
{{forresearchers}}
Go back to [[Finland]] page
Go back to [[Finland]] page
'''Type of database:''' [[databaseType::clinical trial database]]; [[databaseType::research study]].


'''Primary purpose:''' Store the sample collection and data information of participants from the study "The alpha-tocopherol, beta-carotene lung cancer prevention study", which was a randomized, double-blinded, placebo-controlled trial testing whether alpha-tocopherol
'''Primary purpose:''' Store the sample collection and data information of participants from the study "The alpha-tocopherol, beta-carotene lung cancer prevention study", which was a randomized, double-blinded, placebo-controlled trial testing whether alpha-tocopherol

Revision as of 17:51, 5 June 2024

Go back to Finland page

Type of database: clinical trial database; research study.

Primary purpose: Store the sample collection and data information of participants from the study "The alpha-tocopherol, beta-carotene lung cancer prevention study", which was a randomized, double-blinded, placebo-controlled trial testing whether alpha-tocopherol and/or beta-carotene supplements can reduce the incidence of lung cancer and other cancers.

Sponsor, manager or home institution: THL Biobank.

Type of information: Data Dictionary: ATBC Study. Click here to learn more.

Data level: patient level.

Number of records: About 29,000 sample donors.

Date range: 1985 - 1993

Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.

Data access: not publicly available. Click here to access. Instructions to request data for restricted content click here to access.

Contact information: Click here to access.